Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design

Kidney Int Rep. 2023 Nov 3;9(2):478-481. doi: 10.1016/j.ekir.2023.10.027. eCollection 2024 Feb.
No abstract available

Keywords: FSGS; clopidogrel; drug repurposing; proteinuria.